CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic GHRH analogue. The DAC modification extends plasma half-life by enabling albumin binding, making it a key compound for sustained GH axis research models.
Every batch is independently tested. Download the full COA report for this product.
No COA reports have been linked to this product yet.
Adjust the sliders below to calculate reconstitution volumes and dosing for CJC1295 DAC.
For research use only. Not for human consumption. Always consult published protocols.
Explore similar peptides from this category
We offer custom peptide synthesis services for unique research requirements.